Loss of KDM6A expression has also been associated with other cancers such as multiple myeloma (MM) in which KDM6A mutations lead to low KDM6A expression, resulting in increased proliferation, adhesion and tumorigenicity. The gene discussed is KDM6A; the disease is AL amyloidosis.